Delivra Health Brands Inc. (TSXV:DHB)
0.0750
-0.0050 (-6.25%)
Nov 20, 2026, 10:50 AM EST
Delivra Health Brands Balance Sheet
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 2.85 | 3.3 | 4.2 | 2.72 | 1.08 |
Short-Term Investments | - | - | - | 0.01 | 0.03 |
Cash & Short-Term Investments | 2.85 | 3.3 | 4.2 | 2.73 | 1.11 |
Cash Growth | -13.60% | -21.38% | 53.73% | 146.13% | -78.41% |
Accounts Receivable | 1.57 | 3.13 | 2.69 | 2.54 | 1.51 |
Other Receivables | 0.29 | 0.21 | 0.26 | 0.21 | 0.2 |
Receivables | 1.87 | 3.34 | 2.95 | 2.74 | 1.71 |
Inventory | 2.09 | 2.76 | 1.48 | 2.26 | 2.22 |
Prepaid Expenses | 0.12 | 0.18 | 0.13 | 0.18 | 0.1 |
Other Current Assets | - | - | - | - | 2.34 |
Total Current Assets | 6.93 | 9.58 | 8.76 | 7.92 | 7.49 |
Property, Plant & Equipment | - | 0.03 | 0.1 | 0.18 | 0.27 |
Other Intangible Assets | - | - | 1.19 | 2.47 | 3.68 |
Long-Term Accounts Receivable | - | - | - | - | 0.16 |
Total Assets | 6.93 | 9.61 | 10.05 | 10.56 | 11.59 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 1.06 | 1.34 | 0.71 | 2.19 | 3.58 |
Accrued Expenses | 0.89 | 1.56 | 1.52 | 2.15 | 1.93 |
Current Portion of Long-Term Debt | 0.35 | 0.31 | 0.24 | 0.1 | 0.44 |
Current Portion of Leases | - | - | - | 0.16 | - |
Other Current Liabilities | 0.34 | 0.35 | 0.6 | 0.88 | 0.59 |
Total Current Liabilities | 2.65 | 3.56 | 3.07 | 5.47 | 6.54 |
Long-Term Debt | 2.06 | 1.81 | 1.79 | 1.7 | 1.38 |
Long-Term Leases | - | - | - | - | 0.29 |
Total Liabilities | 4.7 | 5.37 | 4.86 | 7.17 | 8.21 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 148.63 | 148.63 | 148.63 | 148.23 | 148.23 |
Retained Earnings | -172.61 | -170.35 | -169.16 | -170.04 | -169.85 |
Comprehensive Income & Other | 26.2 | 25.96 | 25.73 | 25.2 | 25 |
Total Common Equity | 2.22 | 4.24 | 5.19 | 3.39 | 3.37 |
Shareholders' Equity | 2.22 | 4.24 | 5.19 | 3.39 | 3.37 |
Total Liabilities & Equity | 6.93 | 9.61 | 10.05 | 10.56 | 11.59 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 2.41 | 2.11 | 2.03 | 1.96 | 2.11 |
Net Cash (Debt) | 0.44 | 1.19 | 2.17 | 0.78 | -1 |
Net Cash Growth | -62.83% | -45.28% | 180.39% | - | - |
Net Cash Per Share | 0.01 | 0.04 | 0.08 | 0.03 | -0.04 |
Filing Date Shares Outstanding | 31.26 | 31.26 | 31.26 | 25.26 | 25.26 |
Total Common Shares Outstanding | 31.26 | 31.26 | 31.26 | 25.26 | 25.26 |
Working Capital | 4.28 | 6.02 | 5.68 | 2.45 | 0.94 |
Book Value Per Share | 0.07 | 0.14 | 0.17 | 0.13 | 0.13 |
Tangible Book Value | 2.22 | 4.24 | 4 | 0.92 | -0.3 |
Tangible Book Value Per Share | 0.07 | 0.14 | 0.13 | 0.04 | -0.01 |
Machinery | 0.48 | 0.48 | 0.83 | 0.83 | 0.83 |
Construction In Progress | - | - | - | - | 0.01 |